Clonidine treatment for short stature

Area of Science:

• Pediatric Endocrinology
• Pharmacology

Background:

• Constitutional growth delay (CGD) is a common condition in children.
• Effective therapeutic interventions for CGD are continuously sought.

Purpose of the Study:

• To evaluate the efficacy of oral clonidine in stimulating linear growth in children with CGD.
• To identify predictors of treatment response and assess the duration of clonidine's effect.

Main Methods:

• A study involving 34 pubertal children diagnosed with CGD.
• Oral administration of clonidine twice daily.
• Monitoring of height velocity changes over 12 months, with subsequent withdrawal and reintroduction phases.

Main Results:

• Increased height velocity was observed in 25 out of 34 children during clonidine treatment.
• A mean growth increment of 4.4 cm/yr was noted in the first 6 months.
• Sustained growth increments were observed in 13 of 22 children after 12 months of treatment.
• A high height standard deviation score and low baseline growth velocity predicted a better response.

Conclusions:

• Oral clonidine is a potentially effective therapy for enhancing linear growth in children with CGD.
• The drug demonstrated a good safety profile with no noticeable side-effects.
• Predictive factors for treatment response were identified, aiding in patient selection.